Little Rock, AR, United States of America

Ivory A Reis

This inventor holds 2 USPTO granted patents. Top assignee: University of Arkansas. Active years: 2003-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ivory A Reis. Retrieved from https://idiyas.com/inventor/ivory-a-reis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2003-2005

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Ivory A Reis

Introduction

Ivory A Reis is a notable inventor based in Little Rock, AR (US). She has made significant contributions to the field of ophthalmology, particularly through her innovative patents. With a total of 2 patents, her work focuses on reducing intraocular fibrin and addressing various intraocular diseases.

Latest Patents

One of her latest patents is centered on the ophthalmologic uses of Protein C. This invention provides a method for reducing intraocular fibrin by administering a pharmacologically effective dose of Protein C to individuals with elevated levels of intraocular fibrin. Additionally, the patent outlines various methods for preventing intraocular fibrin formation, treating intraocular diseases, and reducing intraocular inflammation.

Career Highlights

Ivory A Reis is affiliated with the University of Arkansas, where she continues to advance her research and innovations. Her work has garnered attention for its potential impact on treating eye-related conditions.

Collaborations

Some of her notable coworkers include Thomas L Steinemann and Louis M Fink, who have collaborated with her on various projects.

Conclusion

Ivory A Reis exemplifies the spirit of innovation in the field of ophthalmology, with her patents paving the way for new treatments and methods in eye care. Her contributions are significant and continue to influence the medical community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…